Published in Eur J Clin Microbiol Infect Dis on May 13, 2004
Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev (2008) 2.88
Central nervous system tuberculosis. Afr Health Sci (2011) 1.83
Tuberculous meningitis: diagnosis and treatment overview. Tuberc Res Treat (2011) 1.17
Cerebrospinal fluid adenosine deaminase activity: a complimentary tool in the early diagnosis of tuberculous meningitis. Cerebrospinal Fluid Res (2006) 1.08
A Hospital Based Study on Estimation of Adenosine Deaminase Activity (ADA) in Cerebrospinal Fluid (CSF) in Various Types of Meningitis. J Clin Diagn Res (2014) 1.05
Adenosine deaminase activity is a sensitive marker for the diagnosis of tuberculous pleuritis in patients with very low CD4 counts. PLoS One (2008) 0.94
Sensitivity and specificity of immunocytochemical staining of mycobacterial antigens in the cytoplasm of cerebrospinal fluid macrophages for diagnosing tuberculous meningitis. J Clin Microbiol (2011) 0.86
CSF ADA Determination in Early Diagnosis of Tuberculous Meningitis in HIV-Infected Patients. Scientifica (Cairo) (2016) 0.75
Diagnostic value of sputum adenosine deaminase (ADA) level in pulmonary tuberculosis. Germs (2016) 0.75
The dubious value of cerebrospinal fluid adenosine deaminase measurement for the diagnosis of tuberculous meningitis. BMC Infect Dis (2017) 0.75
A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology (1983) 30.77
Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med (1992) 8.15
A comparison of C/B ratios from studies using receiver operating characteristic curve analysis. J Clin Epidemiol (1999) 3.02
The use of adenosine deaminase assays in the diagnosis of tuberculosis. S Afr Med J (1982) 1.59
Activity of adenosine deaminase in cerebrospinal fluid for the diagnosis and follow-up of tuberculous meningitis in adults. J Infect Dis (1987) 1.36
Detection and typing of human herpesviruses by multiplex polymerase chain reaction. J Virol Methods (1993) 1.26
Cytomegalovirus encephalitis. Ann Intern Med (1996) 1.21
Diagnostic utility of a multiplex herpesvirus PCR assay performed with cerebrospinal fluid from human immunodeficiency virus-infected patients with neurological disorders. J Clin Microbiol (2000) 0.99
Candidal meningitis in HIV-infected patients: analysis of 14 cases. Clin Infect Dis (1997) 0.95
Multiplex polymerase chain reaction for the simultaneous detection and typing of polyomavirus JC, BK and SV40 DNA in clinical samples. J Virol Methods (1999) 0.90
Adenosine deaminase activity in the CSF of patients with aseptic meningitis: utility in the diagnosis of tuberculous meningitis or neurobrucellosis. Clin Infect Dis (1995) 0.84
Tuberculous meningitis. Clinical characteristics and comparison with cryptococcal meningitis in patients with human immunodeficiency virus infection. Arch Neurol (1996) 0.83
Cerebrospinal fluid adenosine deaminase levels in a patient with cryptococcal meningitis. Clin Infect Dis (1992) 0.83
Acute polyradiculopathies in HIV-infected patients. J Neurol (1997) 0.80
Adenosine deaminase activity as a diagnostic aid in tuberculous meningitis. J Infect Dis (1987) 0.78
A continuous method for the estimation of adenosine deaminase catalytic concentration in pleural effusions with a Hitachi 705 discrete analyser. J Clin Chem Clin Biochem (1985) 0.77
[Adenosine deaminase in the cerebrospinal fluid of patients with acquired immunodeficiency syndrome]. Arq Neuropsiquiatr (1995) 0.76
Shortfalls in the use of adenosine deaminase in tuberculous meningitis. Trop Doct (2001) 0.75
Adenosine deaminase in cerebrospinal fluid of cerebral toxoplasmosis in AIDS. Infection (1991) 0.75
[Progressive infiltration of cranial nerves as first manifestation of primary meningeal lymphoma]. Med Clin (Barc) (1993) 0.75
Molecular genetic analysis of fission yeast Schizosaccharomyces pombe. Methods Enzymol (1991) 33.90
The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26
Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med (1992) 8.15
Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int (2008) 6.04
Phosphorylation at Thr167 is required for Schizosaccharomyces pombe p34cdc2 function. EMBO J (1991) 4.59
Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity? Clin Infect Dis (2007) 4.51
Conservation of mitotic controls in fission and budding yeasts. Cell (1989) 3.65
Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1. Nature (1998) 3.36
Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases. J Clin Microbiol (2000) 3.21
A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group. N Engl J Med (1995) 3.04
Mammalian growth-associated H1 histone kinase: a homolog of cdc2+/CDC28 protein kinases controlling mitotic entry in yeast and frog cells. Mol Cell Biol (1989) 2.75
Complementation of the mitotic activator, p80cdc25, by a human protein-tyrosine phosphatase. Science (1990) 2.63
[Current status of tuberculosis in Spain. A precarious health care perspective with regard to developed countries]. Med Clin (Barc) (1995) 2.58
Expression of the SV40 promoter in fission yeast: identification and characterization of an AP-1-like factor. Cell (1988) 2.44
Catalytic wet peroxide oxidation of phenol by pillared clays containing Al-Ce-Fe. Water Res (2005) 2.25
Carnosic acid inhibits the proliferation and migration capacity of human colorectal cancer cells. Oncol Rep (2012) 2.16
Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1995) 2.14
Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study. Medicine (Baltimore) (2001) 2.00
[Would prescription of erythropoiesis-stimulating agents in pre-dialysis change after results from TREAT study?]. Nefrologia (2009) 1.94
Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection. Lancet (1997) 1.93
Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain. Rev Infect Dis (1989) 1.90
Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV). Ann Intern Med (1989) 1.82
Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis (2000) 1.74
Genetic characterization of multidrug-resistant Mycobacterium bovis strains from a hospital outbreak involving human immunodeficiency virus-positive patients. J Clin Microbiol (1997) 1.72
B-type cyclins regulate G1 progression in fission yeast in opposition to the p25rum1 cdk inhibitor. EMBO J (1996) 1.71
PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii. Clin Microbiol Infect (2000) 1.66
Flp1, a fission yeast orthologue of the s. cerevisiae CDC14 gene, is not required for cyclin degradation or rum1p stabilisation at the end of mitosis. J Cell Sci (2001) 1.63
Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study. Clin Microbiol Infect (2014) 1.61
Emerging trends in candidemia: a higher incidence but a similar outcome. J Infect (2012) 1.61
Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDS. J Infect (1990) 1.50
The fission yeast Cdc1 protein, a homologue of the small subunit of DNA polymerase delta, binds to Pol3 and Cdc27. EMBO J (1996) 1.49
'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease. Cell Death Differ (2002) 1.49
Faster isolation of Brucella spp. from blood by isolator compared with BACTEC NR. Diagn Microbiol Infect Dis (1993) 1.48
Regulation of the G1 phase of the cell cycle by periodic stabilization and degradation of the p25rum1 CDK inhibitor. EMBO J (1998) 1.43
Characterization of the genes coding for the putative sigma factor AlgU and its regulators MucA, MucB, MucC, and MucD in Azotobacter vinelandii and evaluation of their roles in alginate biosynthesis. J Bacteriol (1996) 1.42
Daptomycin is safe and effective for the treatment of gram-positive cocci infections in solid organ transplantation. Transpl Infect Dis (2014) 1.41
[Neurological manifestations in patients with sera positive for Borrelia burgdorferi]. Neurologia (1997) 1.40
Dialysis in patients with bilateral nephrectomy for transitional cell carcinoma. Nephron (1995) 1.40
[Tropical pyomyositis]. Enferm Infecc Microbiol Clin (1994) 1.39
[Factorial and discriminant analyses of neuropsychological variables in familial and sporadic late onset Alzheimer disease]. Rev Neurol (2005) 1.39
[Should Hodgkin's disease be considered a diagnostic criterion of AIDS?]. Rev Clin Esp (1992) 1.38
[Tuberculous meningitis caused by resistant microorganisms. Therapeuticfailure in 2 patients with HIV infection and disseminated tuberculosis]. Enferm Infecc Microbiol Clin (1994) 1.38
[Non-Hodgkin's lymphomas associated with the acquired immunodeficiency syndrome. A multicenter clinical study of 77 cases]. Med Clin (Barc) (1995) 1.38
[Recommendation of GESIDA (AIDS Study Group)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (I)]. Enferm Infecc Microbiol Clin (2000) 1.38
Melamine toxicity: one more culprit in calcium kidney lithiasis. Kidney Int (2011) 1.37
Relapse of tuberculosis after treatment in human immunodeficiency virus-infected patients. Arch Intern Med (1997) 1.36
Characterization of the gene coding for GDP-mannose dehydrogenase (algD) from Azotobacter vinelandii. J Bacteriol (1996) 1.35
APC(ste9/srw1) promotes degradation of mitotic cyclins in G(1) and is inhibited by cdc2 phosphorylation. EMBO J (2000) 1.32
Value of PCR for detection of Toxoplasma gondii in aqueous humor and blood samples from immunocompetent patients with ocular toxoplasmosis. J Clin Microbiol (1999) 1.30
Clinical presentation of Bacillus Calmette-Guérin infections in patients with immunodeficiency syndromes. Pediatr Infect Dis J (1989) 1.28
Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients. Eur J Clin Microbiol Infect Dis (1996) 1.28
Transmission of tropical and geographically restricted infections during solid-organ transplantation. Clin Microbiol Rev (2008) 1.27
Human p8 is a HMG-I/Y-like protein with DNA binding activity enhanced by phosphorylation. J Biol Chem (2000) 1.27
Biochemical markers and cardiac troponin I release after radiofrequency catheter ablation: approach to size of necrosis. Am Heart J (1998) 1.23
Regulation of CDK/cyclin complexes during the cell cycle. Int J Biochem Cell Biol (1997) 1.23
Colonization and infection with methicillin-resistant Staphylococcus aureus: associated factors and eradication. Infect Control Hosp Epidemiol (1996) 1.22
Outcome of HCV/HIV-coinfected liver transplant recipients: a prospective and multicenter cohort study. Am J Transplant (2012) 1.22
Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin. Clin Infect Dis (2001) 1.20
MR imaging and CT of central nervous system tuberculosis in the patient with AIDS. Radiol Clin North Am (1995) 1.19
Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J Antimicrob Chemother (2008) 1.19
Presenilin-1-associated abnormalities in regional cerebral perfusion. Neurology (2001) 1.17
Leuconostoc species as a cause of bacteremia: two case reports and a literature review. Eur J Clin Microbiol Infect Dis (1991) 1.17
Intramedullary cysticercosis cured with drug treatment. A case report. Spine (Phila Pa 1976) (1996) 1.17
Group A streptococcal bacteremia. A 10-year prospective study. Medicine (Baltimore) (1997) 1.16
Cloning and expression of the human p8, a nuclear protein with mitogenic activity. Eur J Biochem (1999) 1.14
Ca2+ content and expression of an acidocalcisomal calcium pump are elevated in intracellular forms of Trypanosoma cruzi. Mol Cell Biol (1998) 1.14
Cardiac troponin I and minor cardiac damage: biochemical markers in a clinical model of myocardial lesions. Clin Chem (1998) 1.13
Clues to action of cdc25 protein. Nature (1991) 1.13
Decline of a visceral leishmaniasis epidemic in HIV-infected patients after the introduction of highly active antiretroviral therapy (HAART). Clin Microbiol Infect (2001) 1.12
Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients. AIDS (1998) 1.12
Ca-125: a useful marker to distinguish pulmonary tuberculosis from other pulmonary infections. Open Respir Med J (2009) 1.11
Group B Streptococcus: a cause of urinary tract infection in nonpregnant adults. Clin Infect Dis (1992) 1.11
Chorea in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis (1988) 1.10
Nocardial infection in patients infected with the human immunodeficiency virus. Clin Microbiol Infect (2003) 1.10
Retinoic acid downregulates Rae1 leading to APC(Cdh1) activation and neuroblastoma SH-SY5Y differentiation. Oncogene (2008) 1.09
Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance. Clin Microbiol Infect (2012) 1.09
Differential localization to cytoplasm, nucleus or P-bodies of yeast PKA subunits under different growth conditions. Eur J Cell Biol (2009) 1.08
The Azotobacter vinelandii alg8 and alg44 genes are essential for alginate synthesis and can be transcribed from an algD-independent promoter. Gene (1997) 1.08
CNS complications in acute malaria: MR findings. AJNR Am J Neuroradiol (1993) 1.07
Epidemiology and clinical features of tuberculosis in immigrants at an infectious diseases department in Madrid. Int J Tuberc Lung Dis (2007) 1.07
Genetic analysis of the transcriptional arrangement of Azotobacter vinelandii alginate biosynthetic genes: identification of two independent promoters. Mol Microbiol (1996) 1.06
Listeriosis in patients infected with human immunodeficiency virus. Rev Infect Dis (1991) 1.05
Widespread exposure to Sarcoptes scabiei in wild European rabbits (Oryctolagus cuniculus) in Spain. Vet Parasitol (2011) 1.04
Bordetella bronchiseptica cavitary pneumonia in a patient with AIDS. Eur J Clin Microbiol Infect Dis (1998) 1.04